Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 4Esophageal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Adenocarcinoma of Lung 4Lung Neoplasms 3Mouth Neoplasms 2Head and Neck Neoplasms 2Barrett Esophagus 2Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Skin Neoplasms 1Salivary Gland Neoplasms 1Precancerous Conditions 1Oropharyngeal Neoplasms 1Laryngeal Neoplasms 1Esthesioneuroblastoma, Olfactory 1Carcinoma, Basal Cell 1Adenocarcinoma, Follicular 1Adenocarcinoma Of Esophagus 1

Interventions

Docetaxel 8Radiotherapy 6Filgrastim 5Cisplatin 5Radiotherapy, Intensity-Modulated 3Etoposide 3Erlotinib Hydrochloride 3Chemotherapy, Adjuvant 3Cetuximab 3Capecitabine 3Bevacizumab 3sargramostim 2Peripheral Blood Stem Cell Transplantation 2Paclitaxel 2Gemcitabine 2Cyclophosphamide 2Carboplatin 2Acupuncture Therapy 2vandetanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1tanespimycin 1pentetreotide 1oncogene protein E7, Human papillomavirus type 16 1olaparib 1oblimersen 1lutetium Lu 177 dotatate 1etoposide phosphate 1entinostat 1enasidenib 1cevimeline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esthesioneuroblastoma, Olfactory × 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a × Clear all
NCT00470496 2022-07-25

Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer

Roswell Park Cancer Institute

Phase 1 Completed
15 enrolled
CNSEndocrineHead & Neck

Squamous Cell Carcinoma of Head and Neck, Thyroid Cancer, Papillary, Salivary Gland Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡